Stay updated with breaking news from Hazel Hunt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) has received a consensus rating of “Hold” from the seven analysts that are covering the firm, Marketbeat.com reports. Four investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Equities researchers at Zacks Research raised their FY2023 EPS estimates for Corcept Therapeutics in a research note issued on Wednesday, August 16th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of $0.75 per share for the year, up from their prior […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider Hazel Hunt sold 20,455 shares of the firm’s stock in a transaction on Monday, August 14th. The stock was sold at an average price of $30.89, for a total transaction of $631,854.95. Following the completion of the sale, the insider now owns 73,146 shares of the […]
CORT earnings call for the period ending December 31, 2021.
Almost everyone knows those actors of the 1950’s and 60’s who rose to fame and fortune on Broadway, on the silver screen and on network television.